Sogo Medical President Shifts Medical Mall Strategy from “New Development to Acquisition” Amidst Fee Revision Changes – Nikkei

News Highlights

Kaoru Fuji, President of Sogo Medical, revealed in an interview with the Nikkei newspaper that the company plans to shift its strategy for developing medical malls from “new development to acquisition.” This move is aimed at accelerating business expansion through M&A in response to the increasingly challenging revenue environment for medical institutions following the FY2024 medical fee revision. While the company has engaged in M&A previously, it will now more actively acquire existing medical institutions to strengthen its business foundation and expand services. This strategic shift is also drawing attention as a response to the overall restructuring of the healthcare industry and the issue of succession issues.

M&A Medical Editorial Perspective

The shift in Sogo Medical’s medical mall strategy from “new development to acquisition,” as announced by President Kaoru Fuji, is more than just a statement of business expansion policy. Against the backdrop of a tougher revenue environment brought about by the FY2024 medical fee revision, positioning M&A as a growth driver is a signal that cannot be overlooked by healthcare facility managers. The fact that the company, which has expanded its medical malls through new openings, is now pivoting to acquisitions suggests that the increased risks and time costs associated with new openings, and more importantly, the succession problems and business continuity challenges faced by existing medical institutions, are making “inventory” readily available in the M&A market. Particularly in rural and smaller cities, acquisitions by large companies like Sogo Medical can be a viable option for the business continuity and maintenance of regional healthcare for clinics and small hospitals struggling with a lack of successors.

Key Discussion Points from This News

• The deteriorating revenue environment due to the medical fee revision has become a catalyst for shifting the medical mall strategy from “new development” to “acquisition.”
• Sogo Medical’s accelerated M&A strategy may further promote the restructuring and consolidation of medical institutions.
• For medical institutions facing succession issues, acquisition by a major player can be a viable option for business continuity.
• The medical mall format is attractive as an M&A target from the perspective of collaboration among various medical departments and operational efficiency.

Practical Questions Arising from This News

• What specific types of medical institutions does Sogo Medical envision acquiring?
• Under what conditions can the directors and presidents of acquired medical institutions consider succession or sale?
• To what extent is the severity of the medical fee revision expected to impact the number of M&A deals in the healthcare sector going forward?

“Should I Consult Too?” If You Feel This Way

Are you also concerned about future succession issues or adapting to the changing medical fee environment at your clinic? Sogo Medical’s strategic shift signals a potential increase in M&A activity within the healthcare sector. If you are considering business succession or expanding/selling your business through M&A, we recommend consulting with specialists promptly to explore the best options tailored to your clinic’s situation. Planning with the future in mind will lead to the sustainable development of your institution.

M&A Medical (CentralMedience Inc.) supports business succession for medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here